Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (1261-1270 of 3,162) with videos related to

Pageof 317
Sort By:
Biochimica Et Biophysica Acta|January 16, 1989
The characterisation of liposomes with covalently attached proteinsF J Hutchinson, S E Francis, I G Lyle, et al.
The American Journal of Emergency Medicine|June 21, 2016
Suicide attempts presenting to trauma centers: trends across age groups using the National Trauma Data BankEva M Mathews, Christopher J Woodward, Mandi W Musso, et al.
Diagnostic Microbiology and Infectious Disease|October 14, 2009
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lotsGary J Moet, Amy A Watters, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|February 5, 2014
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2008
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureusThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 2012
Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010)David J Farrell, Robert K Flamm, Ronald N Jones, et al.
Applied Neuropsychology. Adult|May 16, 2014
Unreliable block span reveals simulated intellectual disability on the stanford-binet intelligence scales-fifth editionAlyse Barker, Mandi Wilkes Musso, Glenn N Jones, et al.
Diagnostic Microbiology and Infectious Disease|January 22, 2014
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011)Michael A Pfaller, Robert K Flamm, Helio S Sader, et al.
International Journal of Antimicrobial Agents|January 14, 2014
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec typesDavid J Farrell, Robert K Flamm, Helio S Sader, et al.
Pageof 317

Showing results (1261-1270 of 3,162) with videos related to

Sort By:
Pageof 317
Biochimica Et Biophysica Acta|January 16, 1989
The characterisation of liposomes with covalently attached proteinsF J Hutchinson, S E Francis, I G Lyle, et al.
The American Journal of Emergency Medicine|June 21, 2016
Suicide attempts presenting to trauma centers: trends across age groups using the National Trauma Data BankEva M Mathews, Christopher J Woodward, Mandi W Musso, et al.
Diagnostic Microbiology and Infectious Disease|October 14, 2009
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lotsGary J Moet, Amy A Watters, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|February 5, 2014
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2008
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureusThomas R Fritsche, Paul R Rhomberg, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 2012
Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010)David J Farrell, Robert K Flamm, Ronald N Jones, et al.
Applied Neuropsychology. Adult|May 16, 2014
Unreliable block span reveals simulated intellectual disability on the stanford-binet intelligence scales-fifth editionAlyse Barker, Mandi Wilkes Musso, Glenn N Jones, et al.
Diagnostic Microbiology and Infectious Disease|January 22, 2014
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011)Michael A Pfaller, Robert K Flamm, Helio S Sader, et al.
International Journal of Antimicrobial Agents|January 14, 2014
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec typesDavid J Farrell, Robert K Flamm, Helio S Sader, et al.
Pageof 317